CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
6.60
+0.09 (1.38%)
At close: Dec 5, 2025, 4:00 PM EST
6.55
-0.05 (-0.76%)
After-hours: Dec 5, 2025, 7:09 PM EST
CNS Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 5.1 | 5.61 | 4.77 | 5.97 | 4.68 | 4.39 | |
| Research & Development | 8.1 | 9.29 | 14.1 | 9.3 | 9.81 | 5.06 | |
| Operating Expenses | 13.2 | 14.9 | 18.87 | 15.27 | 14.49 | 9.45 | |
| Operating Income | -13.2 | -14.9 | -18.87 | -15.27 | -14.49 | -9.45 | |
| Interest Expense | -0.02 | -0.02 | -0.01 | -0.01 | -0.01 | -0 | |
| Interest & Investment Income | 0.14 | 0.06 | 0.03 | - | - | - | |
| EBT Excluding Unusual Items | -13.07 | -14.86 | -18.85 | -15.27 | -14.5 | -9.46 | |
| Pretax Income | -13.07 | -14.86 | -18.85 | -15.27 | -14.5 | -9.46 | |
| Net Income | -13.07 | -14.86 | -18.85 | -15.27 | -14.5 | -9.46 | |
| Net Income to Common | -13.07 | -14.86 | -18.85 | -15.27 | -14.5 | -9.46 | |
| Shares Outstanding (Basic) | 0 | 0 | - | - | - | - | |
| Shares Outstanding (Diluted) | 0 | 0 | - | - | - | - | |
| EPS (Basic) | -41.85 | -466.45 | - | - | - | - | |
| EPS (Diluted) | -41.85 | -466.45 | - | - | - | - | |
| Free Cash Flow | -16.23 | -17.12 | -14.14 | -10.56 | -13.54 | -7.34 | |
| Free Cash Flow Per Share | -51.98 | -537.39 | - | - | - | - | |
| EBITDA | -13.2 | -14.9 | -18.86 | -15.26 | -14.47 | -9.44 | |
| D&A For EBITDA | 0 | 0 | 0 | 0.01 | 0.01 | 0.01 | |
| EBIT | -13.2 | -14.9 | -18.87 | -15.27 | -14.49 | -9.45 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.